Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Editorial: Strategies of virus persistence.

Frontiers in cellular and infection microbiology·2026
Same author

Human cytomegalovirus at the maternal-fetal interface: an overview of pathogenesis, defence, and interventions.

Clinical science (London, England : 1979)·2026
Same author

Changes in the Proteome and Phosphoproteome of <i>Zea mays</i> Tissues in Drought Stress Show Plant Tissue Responses from Dehydrins, Carboxylic Acid Metabolism, RNA Splicing and Transcription Factors.

Proteomes·2026
Same author

Machine learning of intraoperative variables to test feasibility of multivariable prediction modelling for postoperative complications in thoracic surgery: a prospective cohort study.

Journal of thoracic disease·2026
Same author

Inhibition of cytomegalovirus reactivation by ex vivo treatment of human kidneys with the SYN002 immunotoxin.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2026
Same author

Expression of Concern: Inhibiting EGF Receptor or SRC Family Kinase Signaling Overcomes BRAF Inhibitor Resistance in Melanoma.

Cancer discovery·2026
Same journal

Five-Year Risk of CIN3+ After CIN1 Biopsy in a Norwegian Screening Setting: Comparison of CIN1 Diagnosed in a Single Calendar Year and in Two Consecutive Calendar Years.

Pathogens (Basel, Switzerland)·2026
Same journal

Ventilator-Associated Pneumonia (VAP) Prevention Bundle: A Multicenter Cross-Sectional Saudi Study to Assess Knowledge, Adherence, and Perceived Barriers Among ICU Practitioners in Hail Region.

Pathogens (Basel, Switzerland)·2026
Same journal

Anti-<i>Borrelia</i> IgG Seropositivity Among Hemodialysis Patients with Chronic Kidney Disease of Unknown Etiology: A Preliminary Case-Control Study from Northern Türkiye.

Pathogens (Basel, Switzerland)·2026
Same journal

Molecular Characterization of Hemotropic <i>Mycoplasma</i> spp. From Bats (Chiroptera) in the Northern Pantanal, Brazil.

Pathogens (Basel, Switzerland)·2026
Same journal

Characterization of Durum-Einkorn Amphiploids for Introgression of Powdery Mildew Resistance from Einkorn into Common Wheat.

Pathogens (Basel, Switzerland)·2026
Same journal

Human Orthohantavirus Infections: A Narrative Review.

Pathogens (Basel, Switzerland)·2026
See all related articles

Related Experiment Video

Updated: Dec 14, 2025

High Throughput In Vitro Assessment of Latency Reversing Agents on HIV Transcription and Splicing
07:18

High Throughput In Vitro Assessment of Latency Reversing Agents on HIV Transcription and Splicing

Published on: January 22, 2019

6.1K

Understanding HCMV Latency Using Unbiased Proteomic Analyses.

Emma Poole1, John Sinclair1

  • 1Department of Medicine, University of Cambridge, box 157, Level 5 Addenbrooke's Hospital, Hills Road, Cambridge CB2 0QQ, UK.

Pathogens (Basel, Switzerland)
|July 24, 2020
PubMed
Summary
This summary is machine-generated.

Human cytomegalovirus (HCMV) establishes latent or lytic infections based on cell type. This review focuses on proteomic analyses of undifferentiated myeloid cells to understand HCMV latency mechanisms.

Keywords:
human cytomegaloviruslatencyproteome

More Related Videos

Humanized NOD/SCID/IL2r&#947;null (hu-NSG) Mouse Model for HIV Replication and Latency Studies
07:10

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies

Published on: January 7, 2019

16.1K
Measurement of &#947;HV68 Infection in Mice
13:22

Measurement of γHV68 Infection in Mice

Published on: November 22, 2011

13.9K

Related Experiment Videos

Last Updated: Dec 14, 2025

High Throughput In Vitro Assessment of Latency Reversing Agents on HIV Transcription and Splicing
07:18

High Throughput In Vitro Assessment of Latency Reversing Agents on HIV Transcription and Splicing

Published on: January 22, 2019

6.1K
Humanized NOD/SCID/IL2r&#947;null (hu-NSG) Mouse Model for HIV Replication and Latency Studies
07:10

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies

Published on: January 7, 2019

16.1K
Measurement of &#947;HV68 Infection in Mice
13:22

Measurement of γHV68 Infection in Mice

Published on: November 22, 2011

13.9K

Area of Science:

  • Virology
  • Immunology
  • Cell Biology

Background:

  • Human cytomegalovirus (HCMV) infection outcomes (latent vs. lytic) depend on host cell type and differentiation state.
  • Undifferentiated myeloid cells favor latent HCMV infection, while differentiated cells promote lytic infection and viral reactivation.
  • HCMV-associated diseases pose significant clinical burdens, particularly in immunocompromised individuals, driving research into infection control.

Purpose of the Study:

  • To review proteomic analyses investigating molecular changes during HCMV latency.
  • To understand the mechanisms regulating HCMV latency in undifferentiated myeloid cells.

Main Methods:

  • Focus on proteomic analyses in undifferentiated myeloid cells.
  • Examination of cells stably expressing isolated HCMV latency-associated genes.
  • Analysis of cells latently infected with HCMV.

Main Results:

  • Proteomic studies reveal global molecular alterations in latently infected cells.
  • Specific viral latency-associated genes influence cellular proteomes.
  • Cellular differentiation status is a key determinant of HCMV infection outcome.

Conclusions:

  • Proteomic approaches provide unbiased insights into HCMV latency.
  • Understanding HCMV latency mechanisms is crucial for developing novel therapeutic strategies.
  • Further research into HCMV-virulence factor interactions is warranted.